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A best evidence topic in surgery was written according to a structured protocol. The question addressed
was in patients undergoing elective major upper gastrointestinal surgery requiring post-operative
nutritional support, does enteral feeding as compared to total parenteral feeding confer any clinical
beneﬁts. Thirty-two papers were identiﬁed by a search of the Medline and Embase databases, of which
seven represented the best evidence to answer the clinical question. The authors, journal, date and
country of publication, patient group, study group, relevant outcomes and results of these papers were
tabulated. All seven of these papers were randomised controlled trials which demonstrated enteral
nutrition to be associated with shorter hospital stay, lower incidence of severe or infectious complica-
tions, lower severity of complications and decreased cost as compared to parenteral nutrition. For
patients undergoing elective major upper gastrointestinal surgery requiring post-operative nutritional
support, enteral feeding should be considered as the most desirable form of post-operative feeding.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence topic was constructed according to a structured
protocol as described in a previous publication.1
2. Clinical scenario
You are in a multi-disciplinary meeting discussing a patient
scheduled to undergo pancreatic resection for cancer. He has lost
approximately one stone in weight over the last two months and it
is agreed that he requires post-operative nutritional support. A
member of the MDT suggests that this support should be provided
by enteral as opposed to the parenteral route. You resolve to check
the literature to determine whether or not immediate post-
operative enteral feeding confers any clinical beneﬁt as compared
to total parenteral nutrition.
3. Three-part question
In patients undergoing major elective upper GI surgery
requiring post-operative nutritional support, does immediate post-
operative enteral feeding as compared to total parenteral nutrition
(TPN) confer any clinical beneﬁts?.
.
ciates Ltd. Published by Elsevier Lt4. Search strategy
4.1. Using the Medline and Embase interfaces
Key words e “upper gastrointestinal surgery”, esophageal,
esophagus, oesophagus, oesophageal, gastric, pancreatic, biliary,
hepatic, small bowel, small intestine, enteral feeding, parenteral
feeding, enteral nutrition, surgery, resection.
Mesh terms e BILIARY TRACT SURGICAL PROCEDURES
*ESOPHAGECTOMY/OR *GASTRECTOMY/OR *GASTROSTOMY/OR
*HEPATECTOMY/OR *PANCREATECTOMY *ENTERAL NUTRITION
*PARENTERAL NUTRITION, TOTAL.
In addition, the reference lists of relevant papers were searched.
The search was current as of August 2011.5. Search outcome
Thirty-two papers were found using the reported search. From
these seven randomised controlled trials comparing TPN and
enteral feeding were identiﬁed and selected as representing the
best evidence to answer this clinical question.6. Results
The results of these seven papers are summarised in Table 1.d. All rights reserved.
Table 1
Summary of clinical evidence.
Author, date and
country
Study type and
level of evidence
Patient group Outcomes Key results Comments
Braga et al. [2]
2001 Italy
Prospective,
randomised
trial level II
257 pts undergoing
gastrectomy (n ¼ 121),
pancreatectomy (n ¼ 110),
or oesophagectomy (n ¼ 26)
were randomized to receive
post-operative TPN (n ¼ 131)
or SEN (n ¼ 126)
Length of stay (days) TPN 20.7 þ/8.8 vs EEN
19.9 þ/8.2 (no signiﬁcant
difference)
Although this study included
well-nourished elective surgical
patients, a post hoc analysis of
the subgroup of malnourished
patients showing that overall
complication rate was lower in
the EEN group as compared with
the TPN group (37.1% vs 52.0%;
p ¼ 0.23).
Mean cost per day of EEN was
almost four-fold less than TPN
($25 vs $90.60; p < 0.001).
Overall they recommended EEN
as cheaper and lower complications
and length of stay in malnourished
subset.
Infectious complications TPN 30 (22.9%) vs EEN 25
(19.8%) (no signiﬁcant
difference)
Non infectious
complications
TPN 23 (17.5%) vs EEN
20 (15.8%) (no signiﬁcant
difference
Mortality TPN 2 (4.1%) vs EEN 1
(2.3%)
Other outcomes
Nutritional goal
(achieved within 4 days)
TPN 128/131 (97.7%) vs
EEN 100/126 (79.3%)
p < 0.001
First ﬂatus post-op (days) TPN 4.6 þ/2.0 vs EEN
2.4 þ/1.3 p ¼ 0.003
First bowel motion
post-op (days)
TPN 6.3 þ/2.1 vs EEN
4.2 þ/1.6 p ¼ 0.001
Di Carlo et al. [3]
1999 Italy
Prospective,
randomised
trial level II
100 pts undergoing
pancreaticoduodenectomy
(PD) for carcinoma of pancreatic
head were randomised into standard
enteral nutrition (SEN) n ¼ 35,
enteral immunonutrition (IEN)
n ¼ 33, or TPN n ¼ 32.
Length of stay (days) TPN 19.3 þ/8.0 SEN
17.8 þ/6.9
This study had three arms e TPN,
standard enteral nutrition and
immunonutrition.
With respect to TPN vs standard
enteral nutrition there was no
statistical difference with respect
to length of stay, infectious and
non infectious complications.
Resumption of normal bowel
habit was also statistically quicker
in the enterally fed groups
compared to the TPN group,
however this included the
pooled results of the
immunonutrition and
standard enteral feeding
group.
Infectious complications TPN 8/32 (25%) SEN
6/35 (17.2%)
Non infectious
complications
TPN 11/32 (34.3%)
SEN 8/35 (22.8%)
Mortality TPN 2/32 (6.2%)
SEN 0/35 (0%)
Other outcomes
Total complications TPN 19/32 (59.5%)
SEN 14/35 (40.0%)
Severity of complications
(sepsis score)
TPN 10.4 SEN 7.9
Bowel canalization to
gas (days)
TPN 3.8 þ/0.9 SEN/
IEN (pooled results)
2.9 þ/1.0 p < 0.05
Bowel canalization to
faeces (days)
TPN 6.5 þ/1.7 SEN/
IEN 4.4 þ/1.4 p < 0.05
Braga et al. [4]
1998 Italy
Prospective,
randomised
trial level II
166 pts undergoing curative
surgery for gastric or pancreatic
cancer were randomised into
standard enteral nutrition (SEN)
n ¼ 55, enteral nutrition enriched
with arginine, RNA and omega-3
(EEN) n ¼ 55, or TPN n ¼ 56
Length of stay (days) TPN 17.5  6.1 SEN
16.1  5.9
This study had three arms e TPN,
standard enteral nutrition and
enriched enteral nutrition.
Early enteral feeding is a suitable
alternative to TPN after major
abdominal surgery.
With respect to TPN vs standard
enteral nutrition there was no
statistical difference with respect
to length of stay, infectious and
non infectious complications.
Subgroup analysis of pre-
operatively malnourished patients
demonstrated that EEN gave
a signiﬁcant reduction of both severity
of infection and length of stay as
compared with the TPN group.
Subgroup analysis of patients receiving
homologous blood transfusion
demonstrated signiﬁcant advantage
of delivering immunomodulatory
nutrition.
Infectious complications TPN 16/56 (28.5%)
SEN 13/55 (23.6%)
Non infectious
complications
TPN 13/56 (23.2%)
SEN 7/55 (12.7%)
Mortality None reported
Other outcomes
Severity of complications
(sepsis score)
TPN 8.6 SEN 6.5 EEN
4.0 p < 0.05 (enriched
vs TPN group)
Malnourished patient
subgroup: Post-op
infection rates
EEN 16.0%, SEN 25.9%,
TPN 30.7% p < 0.05
(EEN vs TPN)
Transfused patient
subgroups: Post-op
infection rates
EEN 20.0%, SEN 38.4%,
TPN 42.8% p < 0.05
Gianotti et al. [5]
1997 Italy
Prospective,
randomised
trial level II
260 pts undergoing
pancreaticoduodenectomy or
gastrectomy for cancer were
randomised to enteral formula
(EN n ¼ 87), enteral formula
enriched with arginine,
omega-3 fatty acids, and
RNA (immunonutrition (IEN)
group n ¼ 87), and TPN (n ¼ 86)
Length of stay (days) EN 19.2 þ/7.9
TPN 21.6 þ/8.9
This study had three arms e TPN,
standard enteral nutrition and
enteral immunonutrition.
Early post-operative enteral
feeding is a valid alternative
to parenteral feeding in patients
undergoing major surgery.
There was no statistical signiﬁcant
difference demonstrated between
EN and TPN for length of stay and
infectious complications.
Immunonutrition enhances the
host response, induces a switch
from acute-phase to constitutive
proteins, and improves outcome.
Infectious complications EN 20/87 (22.9%)
TPN 24/86 (27.9%)
Non infectious
complications
Not commented on
Mortality Not commented on
Other outcomes
Immune parameters on
day 8 post-op (IL-6 and
prealbumin)
IEN group had better
recovery of the immune
parameters on POD 8
with inverse correlation
between IL-6 and
preambulin levels
(r ¼ 0.766)
(continued on next page)
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Table 1 (continued )
Author, date and
country
Study type and
level of evidence
Patient group Outcomes Key results Comments
Sand et al. [6]
1997 Finland
Prospective,
randomised
trial level II
29 pts undergoing curative
gastrectomy for cancer were
randomised into enteral
(n ¼ 13) and parenteral
feeding (n ¼ 16)
Length of stay (days) Not reported Enteral nutrition post gastrectomy
is safe and well tolerated.
Enteral nutrition found to inﬂuence
signiﬁcantly lower serum CRP
post-operatively.
Enteral nutrition is signiﬁcantly
cheaper than parenteral nutrition.
Infectious complications EN 3/13 (23%)
TPN 5/16 (31%) p ¼ 0.7
Non infectious
complications
EN 3/13 (23%)
TPN 4/16 (24%) (no
signiﬁcant difference)
Mortality (at 45 days) EN 0/13 (0%) TPN 1/16 (3%)
(no signiﬁcant difference)
Other outcomes
Serum CRP at day 6
post-op (g/L)
EN 32 TPN 61 p ¼ 0.02
Reynolds et al. [7]
1997 UK
Prospective,
randomised
trial level II
67 pts undergoing surgery for
oesophageal, gastric, or pancreatic
malignancy were randomised to
post-op enteral (n ¼ 33) or
parenteral (n ¼ 34) feeding
Length of stay (days) Not reported Major upper GI surgery increases
gut permeability and thus systemic
exposure to endotoxin, however
this is not inﬂuenced by enteral
feeding.
No reduction in septic morbidity
or improvement in clinical
outcome observed with EN.
EN 10 times cheaper than TPN
but this was the only basis on
which it could be recommended.
Infectious complications TPN 20/34 (58%) EN 13/33
(39.4%) p ¼ 0.4
Non infectious
complications
TPN 17/34 (50%) EN 13/33
(39.4%) p ¼ 0.3
Mortality TPN 1/34 (2.9%) EN 2/33
(6.1%) p ¼ 0.6
Baigrie et al. [8]
1996 Australia
Prospective,
randomised
trial level II
97 pts undergoing oesophagectomy
or gastrectomy were randomised
into TPN started day 1 post-op
( n ¼ 47) or EN started day 3
post-op (n ¼ 50)
Length of stay Not reported EN demonstrated to be safe.
Although rates of catheter-related
complications were similar, there
were 9 cases requiring active
intervention. The EN complications
were comparatively minor and
rarely required intervention.
TPN is ten times more expensive
than EN, and requires more
sophisticated nursing/biochemical
monitoring.
EN should be preferred to TPN
for post-op feeding.
Infectious
complications
TPN 10/47 (21.3%)
EN 3/50 (6%)
Non infectious
complications
TPN 38/47 (80.8%)
EN 33/50 (66%)
Mortality TPN e 6 (13%): Respiratory
failure 3 (6%) MI/arrest 1
(2%) Anastamotic leak
(fatal) 1 (2%) CVA 1 (2%)
EN group e 4 (8%):
Respiratory failure 1
(2%) MI/arrest 1 (2%)
Anastamotic leak (fatal)
2 (4%)
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It is well-established that upper gastrointestinal (GI) resectional
surgery for malignancy is associated with considerable post-
operative morbidity and mortality. This, in conjunction with the
fact that patients undergoing surgery for cancer are frequently per-
operatively malnourished, means that early nutritional support is
often required. In terms of the technique used to provide post-
operative nutritional support, this can be delivered enterally (via
a nasoejejunal or percutaneous approach), or parenterally via
venous access. Advocates of enteral feeding argue that the small
bowel recovers its ability to absorb nutrients almost immediately
following surgery, even in the absence of peristalsis.9,10 Neverthe-
less, many surgeons traditionally preferred the parenteral as
opposed to the enteral route to administer nutrients after surgery,
citing the need to protect the newly formed anastomosis. To date
seven randomised controlled trials have compared parenteral and
enteral feeding post-operatively in patients undergoing major
upper GI surgery for a number of pathologies.
Baigrie et al.8 presented their paper that randomised a cohort of
97 patients into feeding with TPN at day 1 post-op (n ¼ 47), and
enteral feeding via jejunostomy sited peri-operatively initially with
dextrose on day 3, then feeding compound from day 4 (n ¼ 50).
Their study showed there to be no statistical difference inmortality,
or catheter-related complications although the EN catheter-related
complications were Less severe than those in the TPN group. The
TPN group also encountered signiﬁcantly more non-catheter-
related complications and a higher proportion of life-threatening
complications that the EN group. They concluded that EN was tentimes cheaper than TPN and was associated with a lower incidence
of complications and postulated this reduction in post-operative
septic complications may be due conservation of the GI tract lining.
In their study of sixty-seven patients undergoing surgery for
oesophageal, gastric, or pancreatic malignancy, Reynolds et al.7
randomised their cohort to post-operative enteral feeding
(n ¼ 33) via needle catheter jejunostomy inserted at time of
operation and continued for seven days, or parenteral (n ¼ 34)
feeding started immediately post-operatively and continued for
seven days. Their study showed no signiﬁcant reduction in septic
morbidity, non infectious complications, or mortality. They did
however note that enteral nutrition was ten times cheaper than
parenteral nutrition, and concluded that on this basis alone could it
be recommended.
Sand et al.6 studied a group of twenty-nine patients who
underwent curative gastrectomy for cancer. These were rando-
mised into enteral feeding via nasoejejunal tube (n ¼ 13) and
parenteral feeding (n ¼ 16). They came to much the same conclu-
sions as Reynolds et al., ﬁnding there to be no statistical difference
in infectious complications, non infectious complications, or
mortality at 45 days. They did ﬁnd that the EN group had a signif-
icantly lower CRP on six days post-surgery, although did not
comment on the signiﬁcance of this. They felt that enteral nutrition
after gastrectomy was both safe and well tolerated, as well as being
signiﬁcantly cheaper than parenteral nutrition.
Ginaotti et al.5 studied a group of 260 patients undergoing
pancreaticoduodenectomy or gastrectomy for cancer. These were
randomised to feeding with enteral formula (EN n ¼ 87), enteral
formula enriched with arginine, omega-3 fatty acids, and RNA
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tion (TPN n ¼ 86). They showed no signiﬁcant statistical difference
with respect to length of stay and rates on infectious complications
between the enteral nutrition and TPN groups. However they did
ﬁnd that the group receiving immuno-enriched feeding had
a signiﬁcantly shorter hospital stay comparedwith standard enteral
feed and even more so compared with TPN. They also showed that
the immunonutrition group had lower rates of post-operative
infection, although this did not reach statistical signiﬁcance. They
concluded that early post-operative enteral feeding was a valid
alternative to parenteral feeding in patients undergoing major
surgery whilst enteral immunonutrition improves outcomes as
compared to both standard enteral nutrition and TPN.
Braga et al.4 studied a group of 166 patients undergoing curative
surgery for gastric or pancreatic cancer were randomised into
groups similar to Gianotti et al.; those receiving standard enteral
nutrition (SEN n ¼ 55), enriched enteral nutrition with additional
arginine, RNA and omega-3 (EEN n ¼ 55), or total parenteral
nutrition (TPN n ¼ 56). They failed to demonstrate any signiﬁcant
improvement in the length of stay or rates of complications
between the TPN and SEN groups. They did however show
a statistically signiﬁcantly lower severity of complications in the
enriched enteral nutrition group compared to those receiving TPN,
a pattern which was particularly pronounced in patients known to
be malnourished pre-operatively and those requiring post-
operative transfusion. They concluded that early enteral feeding is
a suitable alternative toTPN aftermajor abdominal surgery and that
enriched enteral feeding diets should be recommended, particu-
larly in high-risk surgical patients.
Di Carlo et al.,3 working in the same unit as Braga and Gianotti
produced a study looking at 100 patients undergoing pan-
creaticoduodenectomy (PD) for carcinoma of the pancreatic head.
They randomised their cohort into groups receiving standard
enteral nutrition (SEN n ¼ 35), enteral immunonutrition (IEN
n ¼ 33), or total parenteral nutrition (TPN n ¼ 32). There was no
statistical difference with respect to length of stay, infectious and
non infectious complications when TPN was compared to standard
enteral nutrition. They did however show that patients receiving
enteral immunonutrition had a signiﬁcantly shorter length of stay,
a lower rate of infectious complications, and rate of total compli-
cations when comparedwith TPN. In addition, when comparing the
pooled results of the groups receiving either standard enteral and
immunonutrition vs TPN, they demonstrate a signiﬁcant decrease
in severity of sepsis, and length of time of canalisation to produc-
tion of ﬂatus and faeces. Their results showed that nutritional goals
post pancreaticoduodenectomy can be achieved by enteral feeding,
and they concluded that enteral nutrition is feasible and a good
alternative to TPN, and TPN should be limited to only patients with
severe intolerance to EN.
Finally, a further group led by Braga in 20012 looked at 257
patients undergoing gastrectomy (n ¼ 121), pancreatectomy
(n ¼ 110), or oesophagectomy (n ¼ 26) who they randomized to
receive post-operative TPN (n ¼ 131) or early standard enteral
nutrition (SEN n ¼ 126). They did not demonstrate any statistical
beneﬁt of SEN over TPN in length of stay, rate of complications
(infectious and non infectious) or mortality. They showed that
a greater proportion of patients achieved their nutritional goals
within 4 days in the TPN group however the SEN group were
signiﬁcantly quicker to resumption of bowel function. A post hocanalysis performed in the subgroup of malnourished patients
showed that overall complication rate was lower in the SEN group
compared to the TPN group. They concluded that inwell-nourished
elective surgical patients, artiﬁcial nutrition by any route is an
auxiliary therapy, although SEN is cheaper and has lower rates of
complications and length of stay in the malnourished subset.8. Clinical bottom line
Enteral feeding immediately followingmajor upper GI surgery is
a suitable alternative to parenteral feeding. Although enteral
feeding does not seem to offer signiﬁcant beneﬁt in rates of
complications or mortality, it does appear to decrease the length of
hospital stay and time to resumption of normal bowel habit.
Furthermore it is signiﬁcantly cheaper than TPN, and in the subset
of malnourished patients, its beneﬁts are increased and thus should
be considered as the preferred method for delivery of post-
operative nutrition.
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